We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCY
4651
Oncolytics Biotech
ONCY
$96M
$6.86K ﹤0.01%
2,639
-13,378
-84% -$22.2K
RBB icon
4652
RBB Bancorp
RBB
$454M
$6.85K ﹤0.01%
574
-1,152
-67% -$13.8K
DALN
4653
DELISTED
DallasNews
DALN
$6.84K ﹤0.01%
1,758
-3,155
-64% -$12.9K
ATHX
4654
DELISTED
Athersys, Inc. Common Stock
ATHX
$6.83K ﹤0.01%
7,855
-1,391
-15% -$1.25K
PHAT icon
4655
Phathom Pharmaceuticals
PHAT
$702M
$6.83K ﹤0.01%
477
-1,228
-72% -$14.2K
BFRI icon
4656
Biofrontera
BFRI
$15.2M
$6.82K ﹤0.01%
655
-7
-1% -$74
PFIN
4657
DELISTED
P&F Industries
PFIN
$6.82K ﹤0.01%
1,089
-273
-20% -$1.59K
CEF icon
4658
Sprott Physical Gold and Silver Trust
CEF
$8.28B
$6.81K ﹤0.01%
378
-100
-21% -$1.89K
PARAP
4659
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
$6.8K ﹤0.01%
300
-4,096
-93% -$106K
LUCY icon
4660
Innovative Eyewear
LUCY
$6.03M
$6.79K ﹤0.01%
379
+84
+28% +$3.64K
NMRD
4661
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$6.78K ﹤0.01%
7,328
+2,695
+58% +$1.94K
SSTI icon
4662
SoundThinking
SSTI
$102M
$6.78K ﹤0.01%
310
+20
+7% +$523
SOPA
4663
DELISTED
Society Pass
SOPA
$6.77K ﹤0.01%
890
+399
+81% +$4.83K
IPW icon
4664
iPower
IPW
$735K
$6.77K ﹤0.01%
3
-2
-40% -$3.18K
TTCF
4665
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$6.76K ﹤0.01%
12,391
+4,199
+51% +$4.28K
SRTS icon
4666
Sensus Healthcare
SRTS
$50.5M
$6.74K ﹤0.01%
2,139
-1,666
-44% -$6.02K
NUV icon
4667
Nuveen Municipal Value Fund
NUV
$1.9B
$6.73K ﹤0.01%
+774
New +$6.81K
MPX
4668
DELISTED
Marine Products Corp
MPX
$6.73K ﹤0.01%
399
-556
-58% -$8.21K
OPTN
4669
DELISTED
OptiNose
OPTN
$6.72K ﹤0.01%
364
-72
-17% -$1.7K
MOG.B icon
4670
Moog Inc Class B
MOG.B
$6.71K ﹤0.01%
62
RAVE icon
4671
RAVE Restaurant Group
RAVE
$43.1M
$6.71K ﹤0.01%
3,324
+404
+14% +$670
RNTX
4672
Rein Therapeutics
RNTX
$69.5M
$6.7K ﹤0.01%
3,742
+429
+13% +$661
PCTI
4673
DELISTED
PCTEL, Inc. Common Stock
PCTI
$6.67K ﹤0.01%
1,392
-7,278
-84% -$34.2K
BLV icon
4674
Vanguard Long-Term Bond ETF
BLV
$5.71B
$6.67K ﹤0.01%
89
-100
-53% -$7.51K
PKE icon
4675
Park Aerospace
PKE
$815M
$6.65K ﹤0.01%
482
-10,855
-96% -$144K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.